NCT03519230 2026-03-16Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian CancerBeOne MedicinesPhase 3 Active not recruiting224 enrolled
NCT03749187 2026-03-13PNOC017University of California, San FranciscoPhase 1 Active not recruiting78 enrolled